Home

Tiaki is working

to provide disease-modifying therapeutics that benefit patients with age-related dementias.

We have a

deep understanding

of microglia functions, and what critical functions are lost in the causes of dementia. This biological mindset will allow Tiaki to better predict microglia targets for the development of disease modifying therapeutics.

 

 

 

50

MILLION people affected with dementia worldwide

$1

TRILLION projected healthcare costs for 2018

0

DISEASE-MODIFYING TREATMENTS after a decade of research and cinical trials

Contact Us

Subject (required)

E-mail (required)

Name (required)

Phone

Message (required)


Tiaki will never give or sell your data to a third party.